Michitaka Honda
Papers
1
Total Citations
2
H-Index
1
About
Dr. Michitaka Honda is a leading figure in surgical oncology, with a focused expertise in minimally invasive gastrectomy for gastric cancer. His research is pivotal in redefining the standard of care for locally advanced proximal gastric cancer, particularly for tumors invading the greater curvature. Dr. Honda’s major contribution is his leadership in the JCOG1809 trial, a single-arm phase II study evaluating the safety of laparoscopic or robotic total gastrectomy with spleen-preserving splenic hilar dissection. This work challenges the traditional open total gastrectomy combined with splenectomy (OTG+S), which, while aiming for complete lymph node clearance, is associated with high postoperative morbidity. By exploring a spleen-preserving, minimally invasive approach, Dr. Honda is pioneering efforts to reduce severe complications without compromising oncological outcomes. Although a relatively recent publication (2023), this trial has already garnered significant attention, signaling its potential to shift clinical practice. Dr. Honda’s work is instrumental for surgeons and researchers seeking to balance radical oncologic resection with enhanced recovery and quality of life for patients.
Research Focus
Key Achievements
Top Papers
- 1